ANSWER: The completion of the Human Genome Project
EXPLANATION:
Human Genome Project (HGP) was completed in April, 2003. Genome varies from one individual to another.
The project involved mapping and sequencing of some people and in other to get each chromosome full sequence in individuals.
However, at the beginning of this project, concerns like ownership and privacy of personal genetic information began to spring up. People are afraid that employers may have access to their genetic information and would reject persons with health issues indicated by their unique genes and health insurance companies may also not provide insurance to people that have deficiency.
In the view of this concern, the United States in 1996 passed the Health Insurance Portability and Accountability Act (HIPAA) which guides against the non-consensual and unauthorized release of health information of individuals.
Answer:
There is no cure for cystic fibrosis, but treatment can ease symptoms and reduce complications.
Explanation:
1). For those with cystic fibrosis who have certain gene mutations, doctors may recommend a newer medication called ivacaftor. This medication may improve lung function and weight, increases the activity of Cystic fibrosis transmembrane conductance regulator (CFTR)protein and reduce the amount of salt in sweat. It has been approved by the Food and Drug Administration for people with cystic fibrosis who are age 6 and older. The dose depends on your weight and age.
2). For people with a certain gene mutation who are age 12 and older, another drug is available that combines ivacaftor with a medication called lumacaftor. This drug is called orkambi.
The use of Orkambi may improve lung function and reduce the risk of exacerbations.
I hope you're clear on this Daxxy
Answer:
The identification of gaps from systematic reviews is essential to the practice of “evidence-based research.” Health care research should begin and end with a systematic review. A research gap may not be a research need if filling the gap would not be of use to stakeholders that make decisions in health care.
Explanation:
Mitochondria should be the answer
The factor that CITES fail to consider when determining which species to cover is the Ecosystem sustainability.
A sustainable ecosystem is a biological environment with a series of habitats that is able to thrive and also support itself without outside influence. it is the capacity of the biosphere to meet the needs of the present generation, without hindering future generations from being able to meet their needs.
